DOCSLIB.ORG

Heberden Society

Total Page：16

File Type：pdf, Size：1020Kb

Download full-text PDF Read full-text
Heberden Society Ann Rheum Dis: first published as 10.1136/ard.25.1.86-b on 1 January 1966. Downloaded from Ann. rheum. Dis. (1966), 25, 86 HEBERDEN SOCIETY OFFICERS, 1966 Junior Hon. Secretary: Dr. J. A. Cosh President: Dr. Oswald Savage Hon. Librarian: Dr. W. S. C. Copeman President-Elect: Dr. J. J. R. Duthie PROGRAMME OF MEETINGS, 1966 March 25: Clinical Meeting, Rheumatism Research Hon. Treasurer: Wing, Birmingham. May 20: Meeting at Harrogate. Dr. F. Dudley Hart October 7: Heberden Round conducted by Dr. R. M. Mason at the London Hospital. Senior Hon. Secretary: November 18: Heberden Oration by Prof. E. G. L. Dr. C. F. Hawkins, Bywaters and Annual General Meeting at the Wellcome Rheumatism Research Wing, Foundation, London. Annual Dinner at the Royal Queen Elizabeth Hospital, Birmingham, 15 College of Physicians, Regents Park, London. by copyright. DR. HUGH CLEGG Dr. Hugh Clegg retired from the Editorship of the in 1945, soon after the war. He has always exerted an British Medical Journal at the beginning of this year and active influence and rheumatology in Great Britain owes so also from the Editorial Board of the Annals. It was him much. due to his foresight and help that our Journal was The Editor and members of the Editorial Committee adopted by the British Medical Association as one of and Board will miss his wise guidance, but wish him well their quarterly specialist journals which he inaugurated in his retirement. http://ard.bmj.com/ LIGUE INTERNATIONALE CONTRE LE RHUMATISME XI International Congress of Rheumatology, Argentina, 1965 on September 28, 2021 by guest. Protected The report of the Secretary-General, which was Organization. In 1963 the Pan-American section presented at the recent Congress held at Mar del co-sponsored a Symposium on Rheumatic Fever in Plata, Argentina, from December 5 to 11, 1965, the Americas. The President and Secretaries of the mentioned the progress made during the past 4 Ligue have recently been appointed ex-officio years, but stressed the continuing shortage of funds members of the advisory Committee on Arthritis for In more cheerful vein he reported the increasing the International Society for Rehabilitation of the interest in rheumatology which had been stimulated Disabled (ISRD). Plans are in hand for a further in the World Health Organization (WHO) since the intensification of effort and an improvement in the publication of the excellent Report of its Expert financial structure of the Ligue. Committee on Rheumatic Diseases (No. 78) in 1954. Professor Delbarre of Paris has been appointed The Congress was attended by over a thousand representative of the Ligue to the World Health doctors; 347 scientific papers were read and another 86 Ann Rheum Dis: first published as 10.1136/ard.25.1.86-b on 1 January 1966. Downloaded from LIGUE INTERNATIONALE CONTRE LE RHUMATISME 87 forty were accepted by title only. Teaching sym- urethral cells in 24 out of thirty and in the synovial posia took the form of up-to-date reviews of fluid cells in ten out ofsixteen patients with this syndrome. progress in the following fields: biology and patho- logy of connective tissue; nomenclature and classi- Clinical Studies.-Three papers, from Curry and fication; immunology; experimental models of others (London Hospital), de S6ze and his colleagues arthritis; gout; epidemiology; osteo-arthritis; re- (Paris), and Serre and co-workers (Paris), discussed the articularis. The two new and orthopaedic measures; thera- problem of chondrocalcinosis habilitation points which emerged from these papers were, first, that peutics. For the first time, simultaneous translation haemochromatosis had to be added to the list of diseases was available at all the sessions of the Congress. which could predispose articular cartilage to calcification (and it was confirmed that the radio-opacity was due to calcium salts and not to deposited iron) and secondly, Education.-The Congress itself was preceeded by an that a much more exact technique of crystallography international forum on education in rheumatism. This than that commonly employed was needed for the was a valuable session, since it produced for the first time internationally agreed minimum standards for the further study and analysis of this phenomenon. training of rheumatologists and the establishment of The surgery of rheumatoid arthritis attracted a number rheumatism units in relationship to the numbers of of review papers, but few new principles emerged except population and facilities for research and university perhaps that of the so-called hemi-arthroplasty of the education. It is to be hoped that the recommendations knee described by Swanson (Toronto) and based on the of this forum will be published in the Annals at a later work of his surgical colleague, Macintosh. The total date. experience of this operation was over 170 cases with up to 11 years' follow-up. However, Swanson's paper re- Experimental Studies.-Of the experimental work, the viewed only those 56 operations done in 36 patients with star paper was undoubtedly that of W. J. Fahlberg and rheumatoid arthritis with a follow-up of at least 3 years. his colleagues from Baylor, Texas. They had developed Striking relief of pain occurred in all, without loss of a new and successful technique for the culture of myco- movement, and, unexpectedly, a reduction in the titre of plasma organisms from swine arthritis, using a medium rheumatoid factor in some. The operation was par- containing mucins, and with this they had fulfilled ticularly indicated in flexed and/or laterally unstable by copyright. Koch's postulates-for the pig. Using the same knees and could be combined with wedging procedures techniques, they had isolated an immunologically to correct deformity. Severely bedridden patients were homogeneous mycoplasma strain from the synovial best got up in calipers for a year or so in order to correct fluid or biopsy of seventeen out of nineteen patients with osteoporosis and other adverse factors before sub- juvenile or adult rheumatoid arthritis (RA). Synovial mission to operation. The "hanging hip" operation of fluid cytology produced a spate of papers and obser- Voss came in for a critical review from Zinn (Bad Ragaz), vations. The "ragocyte" (or to some, the RA cell) is a who had found that on follow-up this operation com- synovial cell which, when examined under phase- pared very unfavourably with the more usual inter- contrast microscopy, contains rounded translucent trochanteric osteotomy procedures. Rehabilitation or, bodies. These vary in number from one or two, to such when necessary, second operations were severely http://ard.bmj.com/ a large mass that the cell looks like a transparent black- prejudiced by the Voss procedure. berry. Delbarre and others (Paris) found this cell in Jones and Engleman (California) following histological 50 per cent. of synovial fluids from patients with in- studies pointed out that fat embolism could be the cause flammatory arthritis. The phenomenon did not seem of avascular necrosis of articular bone in corticosteroid- to be related to RA factor, and could be reproduced treated patients. In their patients, this had followed experimentally by inducing an Arthus reaction in animal unusually high doses given for immuno-suppressive joints, suggesting that it represented the pinocytosis of reasons. In an interesting discussion, they suggested soluble antigen-antibody (AG-AB) complexes. Broder that fat embolism might arise from fatty changes in the on September 28, 2021 by guest. Protected and Baumal (Toronto) had found circulating AG-AB liver, and similarly that fatty livers might account for the complexes in rheumatoid arthritis which were chemically avascular necroses which sometimes occur in severe distinct from rheumatoid factor and had the property of alcoholism. It was suggested that fat embolization, causing tissue injury. (It seemed that these rather than from rupture offat-bearing cells, rather than free nitrogen rheumatoid factor might be the cause of the specific gas bubbles, might be the immediate cause of bone pain inclusions of the ragocyte.) A similar inclusion body and avascular necrosis in Caisson disease. Bravo was studied in RA and other inflammatory arthritides by (Denver) had noted arthritis of various sorts (including Wilkens and Healey (Seattle) who also found that its five patients with avascular necrosis of bone) in 43 * 6 per presence correlated with inflammation but not with cent. of 55 patients surviving operations for renal trans- rheumatoid factor either in the synovial fluid or in plants. Thompson (Newcastle) and McEwen and extracts of leucocytes from the effusion. Pekin (New Kulka (New York and Boston) read papers of con- Jersey) found a distinctive and previously unrecorded siderable academic interest to those concerned with the leucocyte-containing macrophage in the synovial fluid of classification of chronic arthritis. On the basis of eight patients with Reiter's syndrome, and Coste (Paris) capillary microscopy and three-dimensional recon- reviewed studies on virus-like inclusions found in struction of the small vessels of the skin, they had shown Ann Rheum Dis: first published as 10.1136/ard.25.1.86-b on 1 January 1966. Downloaded from 88 ANNALS OF THE RHEUMATIC DISEASES that there was a change in the microcirculation of the Another lone voice, heard by some with considerable skin in areas remote from the rash in patients with scepticism, was that of Traut (Chicago) reviewing up to psoriasis and arthritis. Moreover, these changes could 10 years of placebo therapy by tablet or injection. "The be detected in certain patients with sero-negative number of rheumatic patients (mostly with degenerative polyarthritis. Thompson found that a weak or absent joint disease) benefiting from placebos equals or exceeds response to Trafuril (in the absence of therapy) correlated those favourably influenced by any or all methods of well with this capillary change and might be used as a therapy, including salicylates or cortisone." This voice clinical or screening test.
Load more

Recommended publications
  • Osteoporosis in Premenopausal Women: a Clinical Narrative Review by the ECTS and the IOF
    This is a repository copy of Osteoporosis in premenopausal women: a clinical narrative review by the ECTS and the IOF. White Rose Research Online URL for this paper: https://eprints.whiterose.ac.uk/162028/ Version: Accepted Version Article: Pepe, J., Body, J.-J., Hadji, P. et al. (8 more authors) (2020) Osteoporosis in premenopausal women: a clinical narrative review by the ECTS and the IOF. The Journal of Clinical Endocrinology & Metabolism. ISSN 0021-972X https://doi.org/10.1210/clinem/dgaa306 This is a pre-copyedited, author-produced version of an article accepted for publication in Journal of Clinical Endocrinology and Metabolism following peer review. The version of record Jessica Pepe, Jean-Jacques Body, Peyman Hadji, Eugene McCloskey, Christian Meier, Barbara Obermayer-Pietsch, Andrea Palermo, Elena Tsourdi, M Carola Zillikens, Bente Langdahl, Serge Ferrari, Osteoporosis in premenopausal women: a clinical narrative review by the ECTS and the IOF, The Journal of Clinical Endocrinology & Metabolism, dgaa306 is available online at: https://doi.org/10.1210/clinem/dgaa306 Reuse Items deposited in White Rose Research Online are protected by copyright, with all rights reserved unless indicated otherwise. They may be downloaded and/or printed for private study, or other acts as permitted by national copyright laws. The publisher or other rights holders may allow further reproduction and re-use of the full text version. This is indicated by the licence information on the White Rose Research Online record for the item. Takedown If you consider content in White Rose Research Online to be in breach of UK law, please notify us by emailing [email protected] including the URL of the record and the reason for the withdrawal request.
    [Show full text]
  • In the Prevention of Occupational Diseases 94 7.1 Introduction
    Report on the current situation in relation to occupational diseases' systems in EU Member States and EFTA/EEA countries, in particular relative to Commission Recommendation 2003/670/EC concerning the European Schedule of Occupational Diseases and gathering of data on relevant related aspects ‘Report on the current situation in relation to occupational diseases’ systems in EU Member States and EFTA/EEA countries, in particular relative to Commission Recommendation 2003/670/EC concerning the European Schedule of Occupational Diseases and gathering of data on relevant related aspects’ Table of Contents 1 Introduction 4 1.1 Foreword .................................................................................................... 4 1.2 The burden of occupational diseases ......................................................... 4 1.3 Recommendation 2003/670/EC .................................................................. 6 1.4 The EU context .......................................................................................... 9 1.5 Information notices on occupational diseases, a guide to diagnosis .................................................................................................. 11 1.6 Objectives of the project ........................................................................... 11 1.7 Methodology and sources ........................................................................ 12 1.8 Structure of the report .............................................................................. 15 2 Developments
    [Show full text]
  • European Conference on Rare Diseases
    EUROPEAN CONFERENCE ON RARE DISEASES Luxembourg 21-22 June 2005 EUROPEAN CONFERENCE ON RARE DISEASES Copyright 2005 © Eurordis For more information: www.eurordis.org Webcast of the conference and abstracts: www.rare-luxembourg2005.org TABLE OF CONTENT_3 ------------------------------------------------- ACKNOWLEDGEMENTS AND CREDITS A specialised clinic for Rare Diseases : the RD TABLE OF CONTENTS Outpatient’s Clinic (RDOC) in Italy …………… 48 ------------------------------------------------- ------------------------------------------------- 4 / RARE, BUT EXISTING The organisers particularly wish to thank ACKNOWLEDGEMENTS AND CREDITS 4.1 No code, no name, no existence …………… 49 ------------------------------------------------- the following persons/organisations/companies 4.2 Why do we need to code rare diseases? … 50 PROGRAMME COMMITTEE for their role : ------------------------------------------------- Members of the Programme Committee ……… 6 5 / RESEARCH AND CARE Conference Programme …………………………… 7 …… HER ROYAL HIGHNESS THE GRAND DUCHESS OF LUXEMBOURG Key features of the conference …………………… 12 5.1 Research for Rare Diseases in the EU 54 • Participants ……………………………………… 12 5.2 Fighting the fragmentation of research …… 55 A multi-disciplinary approach ………………… 55 THE EUROPEAN COMMISSION Funding of the conference ……………………… 14 Transfer of academic research towards • ------------------------------------------------- industrial development ………………………… 60 THE GOVERNEMENT OF LUXEMBOURG Speakers ……………………………………………… 16 Strengthening cooperation between academia
    [Show full text]
  • LIST of OCCUPATIONAL DISEASES (Revised 2010)
    LIST OF OCCUPATIONAL DISEASES (revised 2010) Identification and recognition of occupational diseases: Criteria for incorporating diseases in the ILO list of occupational diseases Occupational Safety and Health Series, No. 74 List of occupational diseases (revised 2010) Identification and recognition of occupational diseases: Criteria for incorporating diseases in the ILO list of occupational diseases INTERNATIONAL LABOUR OFFICE • GENEVA Copyright © International Labour Organization 2010 First published 2010 Publications of the International Labour Office enjoy copyright under Protocol 2 of the Universal Copyright Convention. Nevertheless, short excerpts from them may be reproduced without authorization, on condition that the source is indicated. For rights of reproduction or translation, application should be made to ILO Publications (Rights and Permissions), International Labour Office, CH-1211 Geneva 22, Switzerland, or by email: pubdroit@ ilo.org. The International Labour Office welcomes such applications. Libraries, institutions and other users registered with reproduction rights organizations may make copies in accordance with the licences issued to them for this purpose. Visit www.ifrro.org to find the reproduction rights organization in your country. ILO List of occupational diseases (revised 2010). Identification and recognition of occupational diseases: Criteria for incorporating diseases in the ILO list of occupational diseases Geneva, International Labour Office, 2010 (Occupational Safety and Health Series, No. 74) occupational disease / definition. 13.04.3 ISBN 978-92-2-123795-2 ISSN 0078-3129 Also available in French: Liste des maladies professionnelles (révisée en 2010): Identification et reconnaissance des maladies professionnelles: critères pour incorporer des maladies dans la liste des maladies professionnelles de l’OIT (ISBN 978-92-2-223795-1, ISSN 0250-412x), Geneva, 2010, and in Spanish: Lista de enfermedades profesionales (revisada en 2010).
    [Show full text]
  • ICD-10 International Statistical Classification of Diseases and Related Health Problems
    ICD-10 International Statistical Classification of Diseases and Related Health Problems 10th Revision Volume 2 Instruction manual 2010 Edition WHO Library Cataloguing-in-Publication Data International statistical classification of diseases and related health problems. - 10th revision, edition 2010. 3 v. Contents: v. 1. Tabular list – v. 2. Instruction manual – v. 3. Alphabetical index. 1.Diseases - classification. 2.Classification. 3.Manuals. I.World Health Organization. II.ICD-10. ISBN 978 92 4 154834 2 (NLM classification: WB 15) © World Health Organization 2011 All rights reserved. Publications of the World Health Organization are available on the WHO web site (www.who.int) or can be purchased from WHO Press, World Health Organization, 20 Avenue Appia, 1211 Geneva 27, Switzerland (tel.: +41 22 791 3264; fax: +41 22 791 4857; e-mail: [email protected]). Requests for permission to reproduce or translate WHO publications – whether for sale or for noncommercial distribution – should be addressed to WHO Press through the WHO web site (http://www.who.int/about/licensing/copyright_form). The designations employed and the presentation of the material in this publication do not imply the expression of any opinion whatsoever on the part of the World Health Organization concerning the legal status of any country, territory, city or area or of its authorities, or concerning the delimitation of its frontiers or boundaries. Dotted lines on maps represent approximate border lines for which there may not yet be full agreement. The mention of specific companies or of certain manufacturers’ products does not imply that they are endorsed or recommended by the World Health Organization in preference to others of a similar nature that are not mentioned.
    [Show full text]
  • FAQ REGARDING DISEASE REPORTING in MONTANA | Rev
    Disease Reporting in Montana: Frequently Asked Questions Title 50 Section 1-202 of the Montana Code Annotated (MCA) outlines the general powers and duties of the Montana Department of Public Health & Human Services (DPHHS). The three primary duties that serve as the foundation for disease reporting in Montana state that DPHHS shall: • Study conditions affecting the citizens of the state by making use of birth, death, and sickness records; • Make investigations, disseminate information, and make recommendations for control of diseases and improvement of public health to persons, groups, or the public; and • Adopt and enforce rules regarding the reporting and control of communicable diseases. In order to meet these obligations, DPHHS works closely with local health jurisdictions to collect and analyze disease reports. Although anyone may report a case of communicable disease, such reports are submitted primarily by health care providers and laboratories. The Administrative Rules of Montana (ARM), Title 37, Chapter 114, Communicable Disease Control, outline the rules for communicable disease control, including disease reporting. Communicable disease surveillance is defined as the ongoing collection, analysis, interpretation, and dissemination of disease data. Accurate and timely disease reporting is the foundation of an effective surveillance program, which is key to applying effective public health interventions to mitigate the impact of disease. What diseases are reportable? A list of reportable diseases is maintained in ARM 37.114.203. The list continues to evolve and is consistent with the Council of State and Territorial Epidemiologists (CSTE) list of Nationally Notifiable Diseases maintained by the Centers for Disease Control and Prevention (CDC). In addition to the named conditions on the list, any occurrence of a case/cases of communicable disease in the 20th edition of the Control of Communicable Diseases Manual with a frequency in excess of normal expectancy or any unusual incident of unexplained illness or death in a human or animal should be reported.
    [Show full text]
  • National Policy for Rare Diseases, 2021
    NATIONAL POLICY FOR RARE DISEASES, 2021 Table of Contents 1. BACKGROUND 2. RARE DISEASES – ISSUES & CHALLENGES 3. THE INDIAN SCENARIO 4. EXPERIENCES FROM OTHER COUNTRIES 5. NEED TO BALANCE COMPETING PRIORITIES 6. DEFINITION & DISEASES COVERED 7. POLICY DIRECTION 8. PREVENTION AND CONTROL 9. CENTRES OF EXCELLENCE AND NIDAN KENDRA 10. GOVERNMENT OF INDIA SUPPORT IN TREATMENT 11. DEVELOPMENT OF MANPOWER 12. CONSTITUTION OF CONSORTIUM 13. INCREASING AFFORDABILITY OF DRUG RELATED TO RARE DISEASES 14. IMPLEMENTATION STRATEGY 2 1. Background Ministry of Health and family Welfare, Government of India formulated a National Policy for Treatment of Rare Diseases (NPTRD) in July, 2017. Implementation of the policy, however, faced certain challenges. A limiting factor in its implementation was bringing States on board and lack of clarity on how much Government could support in terms of tertiary care. Public Health and Hospitals is primarily a State subject. Stakeholder consultation with the State Governments at the draft stage of formulation of the policy could not be done in an elaborate manner. When the policy was shared with State Governments, issues such as cost effectiveness of interventions for rare disease vis- a-vis other health priorities, the sharing of expenditure between Central and State Governments, flexibility to State Governments to accept the policy or change it according to their situation, were raised by some of the State Governments. In the circumstances, though framed with best intent, the policy had implementation challenges and gaps, including the issue of cost effectiveness of supporting such health interventions for limited resource situation, which made it not feasible to implement.
    [Show full text]
  • Assessment of Inherited Disorders and Disorders Related to Breed Standards in Pedigree Dogs and Cats
    Assessment of inherited disorders and disorders related to breed standards in pedigree dogs and cats Bernese Mountain Dog Dutch Shepherd Dog Cavalier King Charles Spaniel & Maine Coon Cat P.M. Douma (9545131) Utrecht University, Faculty of Veterinary Medicine. Yalelaan 1, 3584 CL Utrecht, the Netherlands Supervisors: Drs. L.E. Meijndert and Prof. Dr. J. Rothuizen. Abstract Concerns about dog breeding within closed populations and thus inevitable inbreeding leading to health issues aren’t new but have taken a flight in the last decade. The Dutch media eagerly pays attention and adds to the growing awareness by means of television and the Internet. Especially unhealthy breed characteristics are getting more and more attention. For the Dutch purebred population valid scientific data are to date not available. In order of the Ministry of Economics a large study has been started that basically wants to answer the pressing questions: Are purebreds really less healthy than crossbreeds? Is there a difference even between a purebred with pedigree and its look-alike without? And, consequently, what can be done if so. Our study is a pilot part of that larger scale study and four breeds (three canine, one feline) have been selected to research the main question: To what extend occur harmful breed characteristics and heritable disorders in The Bernese Mountain Dog, The Dutch Shepherd Dog, the Cavalier King Charles Spaniel and the Maine Coon Cat in the Netherlands. To answer this question we first extensively studied literature to get quantitative information and form an initial idea of the problems occurring within these breeds. We categorised those in three lists.
    [Show full text]
  • Osteoporosis in Men: a Review of an Underestimated Bone Condition
    International Journal of Molecular Sciences Review Osteoporosis in Men: A Review of an Underestimated Bone Condition Giuseppe Rinonapoli 1,*, Carmelinda Ruggiero 2 , Luigi Meccariello 3, Michele Bisaccia 1, Paolo Ceccarini 1 and Auro Caraffa 1 1 Orthopaedic and Traumatology Department, University of Perugia, Ospedale S.Maria della Misericordia, S. Andrea delle Fratte, 06156 Perugia, Italy; [email protected] (M.B.); [email protected] (P.C.); [email protected] (A.C.) 2 Orthogeriatric Service, Geriatric Unit, Institute of Gerontology and Geriatrics, Department of Medicine, University of Perugia, Ospedale S.Maria della Misericordia, S. Andrea delle Fratte, 06156 Perugia, Italy; [email protected] 3 Department of Orthopaedics and Traumatology, AORN San Pio “Gaetano Rummo Hospital”, via R.Delcogliano, 82100 Benevento (BN), Italy; [email protected] * Correspondence: [email protected] Abstract: Osteoporosis is called the ‘silent disease’ because, although it does not give significant symptoms when it is not complicated, can cause fragility fractures, with serious consequences and death. Furthermore, the consequences of osteoporosis have been calculated to weigh heavily on the costs of health systems in all the countries. Osteoporosis is considered a female disease. Actually, the hormonal changes that occur after menopause certainly determine a significant increase in osteoporosis and the risk of fractures in women. However, while there is no doubt that women are more exposed to osteoporosis and fragility fractures, the literature clearly indicates that physicians tend to underestimate the osteoporosis in men. The review of the literature done by the authors Citation: Rinonapoli, G.; Ruggiero, C.; shows that osteoporosis and fragility fractures have a high incidence also in men; and, furthermore, Meccariello, L.; Bisaccia, M.; the risk of fatal complications in hip fractured men is higher than that for women.
    [Show full text]
  • History of the Statistical Classification of Diseases and Causes of Death
    Copyright information All material appearing in this report is in the public domain and may be reproduced or copied without permission; citation as to source, however, is appreciated. Suggested citation Moriyama IM, Loy RM, Robb-Smith AHT. History of the statistical classification of diseases and causes of death. Rosenberg HM, Hoyert DL, eds. Hyattsville, MD: National Center for Health Statistics. 2011. Library of Congress Cataloging-in-Publication Data Moriyama, Iwao M. (Iwao Milton), 1909-2006, author. History of the statistical classification of diseases and causes of death / by Iwao M. Moriyama, Ph.D., Ruth M. Loy, MBE, A.H.T. Robb-Smith, M.D. ; edited and updated by Harry M. Rosenberg, Ph.D., Donna L. Hoyert, Ph.D. p. ; cm. -- (DHHS publication ; no. (PHS) 2011-1125) “March 2011.” Includes bibliographical references. ISBN-13: 978-0-8406-0644-0 ISBN-10: 0-8406-0644-3 1. International statistical classification of diseases and related health problems. 10th revision. 2. International statistical classification of diseases and related health problems. 11th revision. 3. Nosology--History. 4. Death- -Causes--Classification--History. I. Loy, Ruth M., author. II. Robb-Smith, A. H. T. (Alastair Hamish Tearloch), author. III. Rosenberg, Harry M. (Harry Michael), editor. IV. Hoyert, Donna L., editor. V. National Center for Health Statistics (U.S.) VI. Title. VII. Series: DHHS publication ; no. (PHS) 2011- 1125. [DNLM: 1. International classification of diseases. 2. Disease-- classification. 3. International Classification of Diseases--history. 4. Cause of Death. 5. History, 20th Century. WB 15] RB115.M72 2011 616.07’8012--dc22 2010044437 For sale by the U.S.
    [Show full text]
  • Prolia® Coding and Billing Information Guide
    Important Safety Information Considerations Contraindications: Prolia® is contraindicated in patients with Serious Infections: In a clinical trial (N= 7808) in women with ® hypocalcemia. Pre-existing hypocalcemia must be corrected prior postmenopausal osteoporosis, serious infections leading to PROLIA for Complete to initiating Prolia®. Prolia® is contraindicated in women who are hospitalization were reported more frequently in the Prolia® group than pregnant and may cause fetal harm. In women of reproductive in the placebo group. Serious skin infections, as well as infections of Claim Submission potential, pregnancy testing should be performed prior to initiating the abdomen, urinary tract and ear were more frequent in patients CODING AND BILLING treatment with Prolia®. Prolia® is contraindicated in patients with a treated with Prolia®. history of systemic hypersensitivity to any component of the product. Endocarditis was also reported more frequently in Prolia®-treated Reactions have included anaphylaxis, facial swelling and urticaria. patients. The incidence of opportunistic infections and the overall Same Active Ingredient: Prolia® contains the same active ingredient incidence of infections were similar between the treatment groups. INFORMATION GUIDE (denosumab) found in XGEVA®. Patients receiving Prolia® should not Advise patients to seek prompt medical attention if they develop signs CORRECT AND COMPLETE PATIENT receive XGEVA®. or symptoms of severe infection, including cellulitis. INFORMATION: Hypersensitivity: Clinically significant hypersensitivity including Patients on concomitant immunosuppressant agents or with impaired Patient name anaphylaxis has been reported with Prolia®. Symptoms have included immune systems may be at increased risk for serious infections. In ® – ID number hypotension, dyspnea, throat tightness, facial and upper airway edema, patients who develop serious infections while on Prolia , prescribers For physician offices using the CMS 1500 should assess the need for continued Prolia® therapy.
    [Show full text]
  • Asia Diagnostic Guide to Aquatic Animal Diseases 402/2
    ISSNO0428-9345 FAO Asia Diagnostic Guide to FISHERIES TECHNICAL Aquatic Animal Diseases PAPER 402/2 NETWORK OF AQUACULTURE CENTRES IN ASIA-PACIFIC C A A N Food and Agriculture Organization of the United Nations A F O F S I I A N T P A ISSNO0428-9345 FAO Asia Diagnostic Guide to FISHERIES TECHNICAL Aquatic Animal Diseases PAPER 402/2 Edited by Melba G. Bondad-Reantaso NACA, Bangkok, Thailand (E-mail: [email protected]) Sharon E. McGladdery DFO-Canada, Moncton, New Brunswick (E-mail: [email protected]) Iain East AFFA, Canberra, Australia (E-mail: [email protected]) and Rohana P. Subasinghe NETWORK OF FAO, Rome AQUACULTURE CENTRES (E-mail: [email protected]) IN ASIA-PACIFIC C A A N Food and Agriculture Organization of the United Nations A F O F S I I A N T P A The designations employed and the presentation of material in this publication do not imply the expression of any opinion whatsoever on the part of the Food and Agriculture Organization of the United Nations (FAO) or of the Network of Aquaculture Centres in Asia-Pa- cific (NACA) concerning the legal status of any country, territory, city or area or of its authorities, or concerning the delimitation of its fron- tiers or boundaries. ISBN 92-5-104620-4 All rights reserved. No part of this publication may be reproduced, stored in a retrieval system, or transmitted in any form or by any means, electronic, mechanical, photocopying or otherwise, without the prior permission of the copyright owner.
    [Show full text]